Efficacy and safety of salmeterol in childhood asthma

European Journal of Pediatrics

Volumn 154, Issue 12, 1995, Pages 983-990

  Lenney, W ^a   Pedersen, S ^b   Boner, A L ^c   Ebbutt, A ^d   Jenkins, M M ^d  

^a ALEXANDRA HOSPITAL   (United Kingdom)

^b KOLDING HOSPITAL   (Denmark)

^c Clinica Pediatrica   (Italy)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Childhood asthma; Clinical trial; Salmeterol

Indexed keywords

CROMOGLYCATE DISODIUM; GLUCOCORTICOID; KETOTIFEN; NEDOCROMIL SODIUM; SALBUTAMOL; SALMETEROL;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SORE THROAT; TACHYCARDIA; TREMOR;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANALYSIS OF VARIANCE; ASTHMA; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MULTICENTER STUDIES; PEAK EXPIRATORY FLOW RATE; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; TIME FACTORS;

EID: 0028793874     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/BF01958642     Document Type: Article

References (15)

1. A twelve-month comparison of salmeterol with salbutamol in asthmatic patients
2. Prevention of exercise-induced asthma by inhaled salmeterol xinafoate
3. Beta2 adrenergic agonists-oral or aerosol for the treatment of asthma
4. Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients
5. Theophylline. Current thoughts on the risks and beenfits of its use in asthma
6. Beta2 agonist therapy: Oral versus inhaled delivery
7. Regular inhaled beta-agonist treatment in bronchial asthma
8. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma
9. The use of beta-agonists and the risk of death and near death from asthma
10. A comparison of the metered dose inhaler and dry powder Diskhaler inhaler formulations of salmeterol in mild to moderate asthmatics
11. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study
12. A three-way cross-over study comparing twice daily dosing of salmeterol 25 μg and 50 μg with placebo in children with mild to moderate reversible airways disease (abstract)
13. Management Of Asthma: A Consensus Statement